朸浚国际(01355)完成收购奥诺香港有限公司 持有倍生生物37.5%股权

公告速递
Mar 06

朸浚国际(01355)此前在2025年12月23日及2026年3月3日发布公告,披露收购奥诺香港有限公司的相关协议条款。根据最新公告信息,各项先决条件均已达成,此次收购已于2026年3月6日顺利完成。

收购事项完成后,朸浚国际集团持有倍生生物集团37.5%的权益。据公告披露的董事会信息显示,朸浚国际执行董事为李芷欣。公告指出,此次交易完成标志着集团在生物医药领域布局进一步拓展。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10